Detecting and Targeting NTRK Fusions in Cancer in the Era of Tumor Agnostic Oncology.

Abstract:

:Gene rearrangements involving the neurotrophic receptor kinase genes NTRK1, NTRK2, and NTRK3 (referred to as TRK, encoding TRKA, TRKB, and TRKC, respectively) result in highly oncogenic fusions. TRK fusions are rare, with a prevalence of < 1% in solid tumors. Detection of TRK fusions can be based on fluorescence in-situ hybridization (FISH), immunohistochemistry (IHC), and next-generation sequencing (NGS), where RNA sequencing is the most sensitive method. Inhibition of TRK fusions with highly selective small-molecule TRK inhibitors (TRKi) such as entrectinib and larotrectinib, results in profound responses in most cancer patients, regardless of cancer histology. Even response in CNS metastases is relatively common. Although responses are often durable, many patients develop resistance to TRKi due to mutations in one of the TRK genes, or due to genetic alterations conferring activation of alternative oncogenic signaling pathways. Second-generation TRKi have been developed, which can overcome some of the TRK resistance mutations. TRKi are well tolerated, with most common adverse events being related to on-target/off-tumor inhibition of TRKs.

journal_name

Drugs

journal_title

Drugs

authors

Rohrberg KS,Lassen U

doi

10.1007/s40265-020-01459-w

subject

Has Abstract

pub_date

2021-01-05 00:00:00

eissn

0012-6667

issn

1179-1950

pii

10.1007/s40265-020-01459-w

pub_type

杂志文章,评审

相关文献

DRUGS文献大全
  • Azelnidipine.

    abstract::Azelnidipine is a new dihydropyridine calcium channel antagonist with selectivity for L-type calcium channels that has recently been approved in Japan for the treatment of patients with hypertension. Results from clinical trials showed that, in 95 patients with mild-to-moderate hypertension, long-term treatment with a...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-200363230-00004

    authors: Wellington K,Scott LJ

    更新日期:2003-01-01 00:00:00

  • Cidofovir.

    abstract::Cidofovir is a nucleotide analogue which inhibits viral DNA polymerase and is effective against human cytomegalovirus (CMV) infection. It is phosphorylated to its active form by cellular enzymes. With the long intracellular half-life of its metabolites, cidofovir can be administered weekly during induction and every o...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-199652020-00006

    authors: Lea AP,Bryson HM

    更新日期:1996-08-01 00:00:00

  • Antacids and ulcer healing. A review of the evidence.

    abstract::There have been a number of controlled trials of antacids in the treatment of patients with peptic ulcer disease. As a general rule the size of studies has been small and there have been difficulties ensuring adequate binding, because of the formulation and taste of the antacids. Despite these difficulties, antacids a...

    journal_title:Drugs

    pub_type: 临床试验,杂志文章,评审

    doi:10.2165/00003495-199142020-00003

    authors: Walt RP,Langman MJ

    更新日期:1991-08-01 00:00:00

  • Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.

    abstract:UNLABELLED:Levonorgestrel 6-capsule subdermal implants (Norplant) are an effective form of reversible contraception. When implanted under the skin of the upper arm, they release drug into the circulation at a relatively constant rate over 5 years. Generally, the cumulative pregnancy rate at the end of 5 years' levonorg...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-199855060-00019

    authors: Coukell AJ,Balfour JA

    更新日期:1998-06-01 00:00:00

  • Fluticasone furoate: intranasal use in allergic rhinitis.

    abstract::Fluticasone furoate nasal spray is a new topical intranasal corticosteroid with enhanced affinity for the glucocorticoid receptor and low systemic exposure, which was recently approved in the US for the treatment of seasonal or perennial allergic rhinitis in adults and in children aged >or=2 years. Fluticasone furoate...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-200767130-00010

    authors: McCormack PL,Scott LJ

    更新日期:2007-01-01 00:00:00

  • Tuberculosis vaccines: current progress.

    abstract::Tuberculosis continues to be a major cause of disease and death throughout the developing world. Chemotherapy is the current method of control but with the continuing emergence of drug resistance, coupled with the reticence of major drug companies to invest in drug discovery, the identification of new vaccines to comb...

    journal_title:Drugs

    pub_type: 杂志文章

    doi:10.2165/00003495-200565170-00002

    authors: Orme IM

    更新日期:2005-01-01 00:00:00

  • Pomalidomide: A Review in Relapsed and Refractory Multiple Myeloma.

    abstract::Pomalidomide (Imnovid®; Pomalyst®), an analogue of thalidomide, is an immunomodulatory agent, with several mechanisms of action (both direct and indirect) thought to be involved in its anti-myeloma activity. Oral pomalidomide is available in several countries for use in combination with low-dose dexamethasone in adult...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-017-0833-y

    authors: Hoy SM

    更新日期:2017-11-01 00:00:00

  • Selectivity of Janus Kinase Inhibitors in Rheumatoid Arthritis and Other Immune-Mediated Inflammatory Diseases: Is Expectation the Root of All Headache?

    abstract::Janus kinase (JAK) is a signal transducer and activator of a protein transcription system that transduces signals from cell surface cytokine and growth factor receptors to the nucleus. Recently developed JAK inhibitors (JAKinibs) inhibit JAKs non-selectively or selectively and down-regulate the effects of correspondin...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-020-01349-1

    authors: Harigai M,Honda S

    更新日期:2020-08-01 00:00:00

  • Suvorexant: first global approval.

    abstract::Suvorexant (Belsomra(®)), a first-in-class, orally active dual orexin-1 receptor and orexin-2 receptor antagonist, has been developed by Merck for the treatment of insomnia. Variations in the levels of the neuropeptides orexin A and orexin B have been linked to circadian rhythms and wakefulness. Orexin-producing neuro...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-014-0294-5

    authors: Yang LP

    更新日期:2014-10-01 00:00:00

  • Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals.

    abstract::Opioid dependence, manifesting as addiction to heroin and pharmaceutical opioids is increasing. Internationally, there are an estimated 15.6 million illicit opioid users. The global economic burden of opioid dependence is profound both in terms of HIV and hepatitis C virus transmission, direct healthcare costs, and in...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/11597520-000000000-00000

    authors: Tetrault JM,Fiellin DA

    更新日期:2012-01-22 00:00:00

  • Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).

    abstract::Part I of this article reviewed the targets against which anti-HIV drugs can be directed, problems in assessing active compounds (e.g. resistance development and use of surrogate end-points). and nucleoside analogues effective against HIV reverse transcriptase. Intensive research is currently being undertaken in labor...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-199345050-00002

    authors: Sandström E,Oberg B

    更新日期:1993-05-01 00:00:00

  • Targeting ROS1 Rearrangements in Non-small Cell Lung Cancer: Crizotinib and Newer Generation Tyrosine Kinase Inhibitors.

    abstract::ROS1 gene rearrangements exist in 1-2% of non-small cell lung cancers, typically occurring in younger, never or light smokers with adenocarcinoma. ROS1 gene fusions are potent oncogenic drivers, the presence of which results in the susceptibility of tumours to ROS1-targeted therapy. Crizotinib was the first tyrosine k...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-019-01164-3

    authors: Morris TA,Khoo C,Solomon BJ

    更新日期:2019-08-01 00:00:00

  • In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.

    abstract::Antibacterial activities of cefotaxime and its major metabolite, desacetylcefotaxime, against 178 strains (of 10 species) were assessed in terms of minimum inhibitory concentrations (MIC50 and MIC80), and were compared with those of cefoperazone and ceftazidime. The activity of desacetylcefotaxime was several times le...

    journal_title:Drugs

    pub_type: 杂志文章

    doi:10.2165/00003495-198800352-00013

    authors: Oizumi K,Hayashi I,Aonuma S,Konno K

    更新日期:1988-01-01 00:00:00

  • Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

    abstract::During the intervening years since metoprolol was first reviewed in the Journal (1977), it has become widely used in the treatment of mild to moderate hypertension and angina pectoris. Although much data have accumulated, its precise mechanisms of action in these diseases remain largely uncertain. Optimum treatment of...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-198631050-00002

    authors: Benfield P,Clissold SP,Brogden RN

    更新日期:1986-05-01 00:00:00

  • Quinolone activity against anaerobes: microbiological aspects.

    abstract::Currently available quinolones are either inactive or marginally active against anaerobic bacteria. This review summarises the in vitro activity of currently available as well as experimental quinolones against clinically significant anaerobic bacteria. Quinolones with low activity against anaerobes include ciprofloxa...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-199500492-00012

    authors: Appelbaum PC

    更新日期:1995-01-01 00:00:00

  • Therapeutic experience with temocillin in peritonitis.

    abstract::The therapeutic efficacy of the new beta-lactam antibiotic, temocillin, was studied in 30 critically ill patients with peritonitis, abscesses, bronchopneumonia, and serious soft tissue infections. Patients were treated with temocillin Ig intravenously twice daily. The isolated pathogens comprised mainly Escherichia co...

    journal_title:Drugs

    pub_type: 杂志文章

    doi:10.2165/00003495-198500295-00042

    authors: Pfeiffer M,Fock RR

    更新日期:1985-01-01 00:00:00

  • Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment.

    abstract::Prostaglandin E2 (PGE2) is a potent stimulator of inflammation, and the inhibition of its synthesis is one possible mechanism of action of non-steroidal anti-inflammatory drugs (NSAIDs). We have investigated patients suffering from rheumatoid arthritis to determine how synovial fluid levels of PGE2 are affected by tia...

    journal_title:Drugs

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.2165/00003495-198800351-00004

    authors: Daymond TJ,Rowell FJ

    更新日期:1988-01-01 00:00:00

  • Zaleplon: a review of its use in the treatment of insomnia.

    abstract::Zaleplon is a pyrazolopyrimidine hypnotic agent which is indicated for the short term (2 to 4 weeks) management of insomnia. Zaleplon 5 and 10 mg at bedtime (usual recommended doses) significantly reduced sleep latency compared with placebo in clinical trials in nonelderly and elderly patients with insomnia. In genera...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-200060020-00014

    authors: Dooley M,Plosker GL

    更新日期:2000-08-01 00:00:00

  • Treatment of sexually transmitted bacterial diseases in pregnant women.

    abstract::Testing for and treating sexually transmitted diseases (STDs) in pregnant women deserves special attention. Treatment possibilities are limited because of potential risks for the developing fetus, and because effects can differ in pregnant compared with non-pregnant women, re-infection may be missed because of the int...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-200059030-00005

    authors: Donders GG

    更新日期:2000-03-01 00:00:00

  • Diuretics. Clinical pharmacology and therapeutic use (Part II).

    abstract::25 years have elapsed since the introduction of the first effective oral diuretic, chlorothiazide. Diuretics are now amongst the most widely prescribed drugs in clinical practice worldwide. Availability of these drugs has not only brought therapeutic benefit to countless numbers of patients but it has at the same time...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-198529020-00003

    authors: Lant A

    更新日期:1985-02-01 00:00:00

  • Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

    abstract::Acinetobacter baumannii is a leading cause of healthcare-associated infections worldwide. Because of various intrinsic and acquired mechanisms of resistance, most β-lactam agents are not effective against many strains, and carbapenems have played an important role in therapy. Recent trends show many infections are cau...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-014-0267-8

    authors: Viehman JA,Nguyen MH,Doi Y

    更新日期:2014-08-01 00:00:00

  • Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date.

    abstract::Infliximab, the chimeric monoclonal antibody directed against tumour necrosis factor (TNF)-alpha, has profoundly changed therapy for Crohn's disease (CD). However, for ulcerative colitis (UC), before the publication of ACT 1 and ACT 2 (Active Ulcerative Colitis Trials 1 and 2), there were only a few open-label and con...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-200666160-00002

    authors: Thukral C,Cheifetz A,Peppercorn MA

    更新日期:2006-01-01 00:00:00

  • Pemphigus vulgaris: an evidence-based treatment update.

    abstract:BACKGROUND:While a variety of intervention options have been described for pemphigus vulgaris, the optimal treatment strategy has not been established. OBJECTIVES:The objective of this systematic review is to assess the literature on the efficacy and safety of interventions for the treatment of pemphigus vulgaris. DA...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-015-0353-6

    authors: Zhao CY,Murrell DF

    更新日期:2015-02-01 00:00:00

  • The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date.

    abstract::The phosphoinositide 3-kinase (PI3K)/Akt/mTOR pathway is implicated in the pathogenesis of lymphoma. Deeper understanding of the diversity and biological impact of this pathway has led to the development of specific inhibitors to this pathway. Preclinical data in cell lines, patient samples and disease models have bro...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-016-0565-4

    authors: Seiler T,Hutter G,Dreyling M

    更新日期:2016-04-01 00:00:00

  • Durability and rapidity of response to anakinra in patients with rheumatoid arthritis.

    abstract::Rheumatoid arthritis (RA) is a chronic and progressive inflammatory disease that ultimately leads to disability and functional decline. Because patients usually develop RA in mid-life, they may experience its consequences for 20-30 years or longer. Proinflammatory cytokines, notably interleukin (IL)-1 and tumour necro...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-200464220-00001

    authors: Schiff MH

    更新日期:2004-01-01 00:00:00

  • Catecholamines: role in health and disease.

    abstract::The naturally occurring catecholamines, noradrenaline, adrenaline and dopamine, have been found in a wide range of animal and vegetable tissues, but are particularly associated with nervous tissue in animals. Of the many processes affecting the response to stimulation of catecholamine containing nerves, the synthesis ...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-197816050-00003

    authors: Laverty R

    更新日期:1978-11-01 00:00:00

  • Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.

    abstract::Osteoporosis is a systemic bone disease characterized by low bone mass and bone mineral density, and deterioration of the underlying structure of bone tissue. These changes lead to an increase in bone fragility and an increased risk for fracture, which are the clinical consequences of osteoporosis. The classical triad...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/11587570-000000000-00000

    authors: Reginster JY

    更新日期:2011-01-01 00:00:00

  • A randomised controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis.

    abstract::74 cirrhotic patients with a history of variceal or gastric bleeding were randomly assigned to treatment with propranolol (40 to 360 mg/day) or placebo. The patients were all in good condition and doses of propranolol were titrated until a 25% reduction in heart rate was achieved. After 2 years, the cumulative percent...

    journal_title:Drugs

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.2165/00003495-198900372-00006

    authors: Lebrec D,Poynard T,Bernuau J,Bercoff E,Nouel O,Capron JP,Poupon R,Bouvry M,Rueff B,Benhamou JP

    更新日期:1989-01-01 00:00:00

  • The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.

    abstract::Until recently, patients with advanced thyroid cancers had limited options for systemic treatment. With the introduction of tyrosine kinase inhibitors (TKIs) as a promising new class of targeted therapies for thyroid cancer, suddenly patients with advanced disease were given new options to extend survival. Guidelines ...

    journal_title:Drugs

    pub_type: 杂志文章

    doi:10.1007/s40265-017-0733-1

    authors: Lirov R,Worden FP,Cohen MS

    更新日期:2017-05-01 00:00:00

  • Fluoroquinolones and surgical prophylaxis.

    abstract::The objective of surgical prophylaxis is to prevent wound infections associated with surgery. The rates of wound infections vary according to the procedure: less than 3 infections per 100 for clean procedures; up to 4 per 100 for clean-contaminated procedures; and up to 9 per 100 for contaminated procedures. Surgical ...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-199300453-00018

    authors: Dellamonica P,Bernard E

    更新日期:1993-01-01 00:00:00